Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease

Rebecca L. Koch, Benjamin T. Cocanougher, Jeong-A Lim, Nina Raben, Priya S. Kishnani